Welcome to our dedicated page for Mistras Group SEC filings (Ticker: MG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Mistras Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Mistras Group's regulatory disclosures and financial reporting.
Natalia Shuman-Fabbri, President and CEO and Director of Mistras Group, Inc. (MG), reported awards on 09/08/2025. The filing shows receipt of 25,000 restricted stock units that vest 100% on the first anniversary of the grant and 35,000 stock options granted with a $9.71 exercise price, exercisable beginning 09/08/2026 and expiring 09/07/2035. Following the transactions she beneficially owns 25,000 shares from the RSUs and 35,000 underlying shares from the options, all held in a direct ownership form. The form was signed by an attorney-in-fact on 09/09/2025.
Mistras Group granted equity awards to its CEO to align her interests with shareholders. On September 8, 2025, the Compensation Committee awarded Natalia Shuman 25,000 restricted stock units (RSUs) and options to purchase 35,000 shares. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant and convert one-for-one into common stock upon vesting. The options have an exercise price of $9.71 (the September 8, 2025 NYSE closing price), become exercisable on or after September 8, 2026, and expire 10 years after the grant date, subject to standard exceptions for termination, death, or disability.
The committee noted Ms. Shuman received no equity at hire and that these awards follow eight months in her role. The Option Agreement and RSU Agreement are filed as exhibits.
Mistras Group, Inc. reported total revenue of $185.4 million for the quarter ended June 30, 2025, down from $189.8 million a year earlier, reflecting a 2.3% decline driven primarily by lower North America oil & gas activity and voluntary laboratory consolidations. Gross profit rose to $53.9 million from $51.3 million, lifting gross margin to 29.1% from 27.1%, while operating income fell to $8.4 million from $12.0 million. The company recorded net income of $3.1 million for the quarter; for the six months the company reported a small net loss of $42 thousand versus net income of $7.4 million in the prior year.
Total assets increased to $571.0 million and accounts receivable rose to $159.8 million, with unbilled revenue of $41.0 million at June 30, 2025. Debt outstanding totaled $189.4 million, and the company drew on its revolver during the period; management states it remains in compliance with its credit covenants and believes it can meet liquidity needs. The filing discloses an active environmental lawsuit in Arizona related to a Phoenix testing facility; remediation costs and penalties are considered probable but not yet estimable, representing a material uncertainty.